Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
5151
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $1.14M | ﹤0.01% |
155,700
+104,000
| +201% | +$884K |
|
5152
PUT
EPR Properties
EPR
$4.69B
| $1.14M | ﹤0.01% |
16,600
+3,100
| +23% | +$211K |
|
|
RETA
5153
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.14M | ﹤0.01% |
+13,900
| New | +$980K |
|
|
CNCE
5154
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.14M | ﹤0.01% |
76,527
-24,132
| -24% | -$380K |
|
|
ONCE
5155
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.14M | ﹤0.01% |
20,800
+700
| +3% | +$47.9K |
|
|
LXFT
5156
DELISTED
Luxoft Holding, Inc.
LXFT
| $1.14M | ﹤0.01% |
23,968
-321,453
| -93% | -$13.6M |
|
|
REV
5157
CALL
DELISTED
Revlon, Inc.
REV
| $1.14M | ﹤0.01% |
50,900
+30,900
| +155% | +$586K |
|
5158
CALL
Teucrium Corn Fund
CORN
$171M
| $1.13M | ﹤0.01% |
71,500
+57,200
| +400% | +$929K |
|
5159
CALL
CVR Energy
CVI
$3.54B
| $1.13M | ﹤0.01% |
28,200
-76,700
| -73% | -$2.88M |
|
|
ENV
5160
PUT
DELISTED
ENVESTNET, INC.
ENV
| $1.13M | ﹤0.01% |
18,600
+8,100
| +77% | +$490K |
|
5161
Teledyne Technologies
TDY
$31.5B
| $1.13M | ﹤0.01% |
4,595
-12,827
| -74% | -$2.92M |
|
|
AMID
5162
DELISTED
American Midstream Partners, LP
AMID
| $1.13M | ﹤0.01% |
178,405
+67,445
| +61% | +$501K |
|
|
LPNT
5163
PUT
DELISTED
LifePoint Health, Inc.
LPNT
| $1.13M | ﹤0.01% |
17,600
+9,700
| +123% | +$591K |
|
|
APLS
5164
DELISTED
Apellis Pharmaceuticals
APLS
| $1.13M | ﹤0.01% |
63,712
+52,445
| +465% | +$969K |
|
5165
Laureate Education
LAUR
$5.18B
| $1.13M | ﹤0.01% |
73,245
-134,228
| -65% | -$2.07M |
|
5166
Oracle
ORCL
$434B
| $1.13M | ﹤0.01% |
21,929
-1,947,482
| -99% | -$94.6M |
|
5167
PUT
Geron
GERN
$943M
| $1.13M | ﹤0.01% |
641,900
+350,800
| +121% | +$1.53M |
|
5168
Gartner
IT
$11.4B
| $1.13M | ﹤0.01% |
7,128
-574,098
| -99% | -$83.2M |
|
5169
CALL
Allegiant Air
ALGT
$2.34B
| $1.13M | ﹤0.01% |
8,900
+100
| +1% | +$13.3K |
|
5170
Sociedad Química y Minera de Chile
SQM
$21.2B
| $1.13M | ﹤0.01% |
24,605
-81,668
| -77% | -$3.76M |
|
|
DGAZ
5171
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
| $1.13M | ﹤0.01% |
+3,003
| New | +$1.39M |
|
5172
Atlanticus Holdings
ATLC
$1.56B
| $1.12M | ﹤0.01% |
379,970
-107,510
| -22% | -$245K |
|
5173
Tucows
TCX
$126M
| $1.12M | ﹤0.01% |
20,142
+1,739
| +9% | +$99.7K |
|
5174
PUT
Encompass Health
EHC
$12.2B
| $1.12M | ﹤0.01% |
18,101
+7,919
| +78% | +$482K |
|
5175
PUT
MGP Ingredients
MGPI
$379M
| $1.12M | ﹤0.01% |
14,200
| – | – |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.